Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lurje

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Oncology|February 5, 2010
EGFR signaling and drug discoveryGeorg Lurje, Heinz-Josef Lenz
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2010
Molecular response prediction in multimodality treatment for adenocarcinoma of the esophagus and esophagogastric junctionGeorg Lurje, Heinz-Josef Lenz
Hepatobiliary Surgery and Nutrition|August 25, 2021
Influence of skeletal muscle mass on graft regeneration after living-donor liver transplantationDeniz Uluk, Johann Pratschke, Georg Lurje
JHEP Reports : Innovation in Hepatology|June 17, 2026
Reply: Enhancing Biliary Protection via HOPE: Beyond Bile Composition to Cholangiocyte ResilienceFrederik Schliephake, Isabella Lurje, Georg Lurje
Gastroenterology|July 28, 2019
Evolving Trends in Machine Liver Perfusion: Comments on Clinical End Points and Selection CriteriaZoltan Czigany, Frank Tacke, Georg Lurje
Clinical Colorectal Cancer|November 28, 2007
Molecular prognostic markers in locally advanced colon cancerGeorg Lurje, Wu Zhang, Heinz-Josef Lenz
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Multimodal treatment strategies in patients undergoing surgery for hepatocellular carcinomaGeorg Lurje, Mickaël Lesurtel, Pierre-Alain Clavien
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 11, 2019
Reply to: Does lymphovascular invasion really associate with decreased overall survival for patients with resected cholangiocarcinoma?Jan Bednarsch, Ulf Peter Neumann, Georg Lurje
Alimentary Pharmacology & Therapeutics|April 4, 2025
Letter: Comparing the Efficacy of Adjuvant PD-1 Inhibitor After Curative Resection for Metabolic Dysfunction-Associated Steatotic Liver Disease Related HCC Versus Other Aetiologies-Authors' ReplyIsabella Lurje, Deniz Uluk, Frank Tacke, et al.
Clinical Colorectal Cancer|May 27, 2008
Stem cells in colon cancerAlexandra Pohl, Georg Lurje, Michael Kahn, et al.
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Oncology|February 5, 2010
EGFR signaling and drug discoveryGeorg Lurje, Heinz-Josef Lenz
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2010
Molecular response prediction in multimodality treatment for adenocarcinoma of the esophagus and esophagogastric junctionGeorg Lurje, Heinz-Josef Lenz
Hepatobiliary Surgery and Nutrition|August 25, 2021
Influence of skeletal muscle mass on graft regeneration after living-donor liver transplantationDeniz Uluk, Johann Pratschke, Georg Lurje
JHEP Reports : Innovation in Hepatology|June 17, 2026
Reply: Enhancing Biliary Protection via HOPE: Beyond Bile Composition to Cholangiocyte ResilienceFrederik Schliephake, Isabella Lurje, Georg Lurje
Gastroenterology|July 28, 2019
Evolving Trends in Machine Liver Perfusion: Comments on Clinical End Points and Selection CriteriaZoltan Czigany, Frank Tacke, Georg Lurje
Clinical Colorectal Cancer|November 28, 2007
Molecular prognostic markers in locally advanced colon cancerGeorg Lurje, Wu Zhang, Heinz-Josef Lenz
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Multimodal treatment strategies in patients undergoing surgery for hepatocellular carcinomaGeorg Lurje, Mickaël Lesurtel, Pierre-Alain Clavien
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 11, 2019
Reply to: Does lymphovascular invasion really associate with decreased overall survival for patients with resected cholangiocarcinoma?Jan Bednarsch, Ulf Peter Neumann, Georg Lurje
Alimentary Pharmacology & Therapeutics|April 4, 2025
Letter: Comparing the Efficacy of Adjuvant PD-1 Inhibitor After Curative Resection for Metabolic Dysfunction-Associated Steatotic Liver Disease Related HCC Versus Other Aetiologies-Authors' ReplyIsabella Lurje, Deniz Uluk, Frank Tacke, et al.
Clinical Colorectal Cancer|May 27, 2008
Stem cells in colon cancerAlexandra Pohl, Georg Lurje, Michael Kahn, et al.
Pageof 18